EastPharma is a pharmaceutical company specialising in the manufacturing and marketing of branded generic pharmaceuticals in selected emerging markets, with a significant presence in Turkey.

Our manufacturing plants are located in Turkey, one of the world’s fastest growing generic pharmaceutical markets, and we sell our products at present to over five countries.

In Turkey, EastPharma controls Deva, a leading Turkish generic pharmaceutical company and Turkish pharmaceutical manufacturer Saba. EastPharma had a market share in Turkey in terms of units sold of 5.2 % as of 30 November 2007 in the human pharmaceuticals segment.

Deva and Saba specialise in the production and marketing of human pharmaceuticals, active pharmaceutical ingredients (API) and veterinary products. These core operations are supported by our consumer goods business lines, which includes ampoule and hygienic products manufacturing. As of 30 November 2007, EastPharma employed a total of 1,952 employees, almost all of whom are located in Turkey.

EastPharma’s organic growth strategy is to continue its growth in Turkey, to boost exports to selected emerging markets and to begin exporting to fully regulated markets in 2008. EastPharma is also seeking to acquire pharmaceutical companies in Turkey and selected emerging markets including Russia, Ukraine, the CIS and certain countries in North Africa and the Middle East which have complementary product portfolios and which can be used to penetrate markets in which EastPharma’s presence is still low.

EastPharma has four business lines:

Human Pharmaceuticals (approximately 88% of revenues in 9M 2007)
APIs (approximately 4%)
Veterinary Products (approximately 5%)
Consumer Goods (approximately 3%).

These business lines represent 85 pharmaceutical products in 217 pharmaceutical forms. Of these, 73 are branded generic products in 198 presentation forms and 12 are licensed products in 19 presentation forms.

The Human Pharmaceutical business line is supported by a strong sales force, which we believe is one of the largest and best trained in the Turkish pharmaceutical market. Our sales force comprises 804 medical and sales representatives who are overseen by 79 regional managers.

We currently operate eight manufacturing units in five campuses. The campuses are in four locations in Turkey. Three of our manufacturing units, located in Levent, Topkapi and Çerkezköy, specialise in the manufacturing of final human pharmaceutical products, two of the units, located in Köseköy and Çerkezköy, manufacture APIs, and two units located in Köseköy manufacture ampoules and hygienic products, respectively. We are also constructing a new production campus in Çerkezköy, expected to be fully operational in March 2008.